Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
306
-
Total 13F shares, excl. options
-
41.1M
-
Shares change
-
-325K
-
Total reported value, excl. options
-
$3.62B
-
Value change
-
-$14.4M
-
Put/Call ratio
-
0.9
-
Number of buys
-
143
-
Number of sells
-
-130
-
Price
-
$88.08
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2019
375 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2019.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 306 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.1M shares
of 44.8M outstanding shares and own 91.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.64M shares), VANGUARD GROUP INC (4.05M shares), RENAISSANCE TECHNOLOGIES LLC (3.54M shares), FMR LLC (2.38M shares), STATE STREET CORP (1.89M shares), Palo Alto Investors LP (1.29M shares), CITADEL ADVISORS LLC (1.23M shares), MILLENNIUM MANAGEMENT LLC (1.11M shares), D. E. Shaw & Co., Inc. (959K shares), and Consonance Capital Management LP (919K shares).
This table shows the top 306 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.